Brolucizumab Therapy for Diabetic Macular Edema Linked With Significant Visual Gains Study compared brolucizumab (6 mg) to aflibercept (2 mg) in the treatment of diabetic macular edema. By Samar Mahmoud, MS Publish Date December 6, 2021
